Not only do HDAC-inhibitors directly influence the tumor, they also lead to a readjustment of the tumor microenvironment27, 28 accompanied by a reduction in glioma-induced neuronal cell death23. This evidence concerns the gene HDAC9 and central nervous system cancer.